Nevezyne
Custom recombinant therapeutic protein expression and purification services for biotechnology and pharmaceutical researchers
Highlights
- Young companyFounded 2023
- New on EvolcAdded 2026-11-09
About Nevezyne
Nevezyne provides custom expression and purification of recombinant proteins, specializing in insect-cell BEVS and also offering E. coli expression. Services include gene synthesis and codon optimization, baculovirus work, and production optimization.
The company serves clients seeking protein production and purification, including custom purification protocols. Nevezyne SAS was founded in 2023 and is based in Saint-Brieuc, France; it lists a biotechnology site in Ploufragan.
Product: Contract services for recombinant protein expression, purification, baculovirus production, and process optimization.
Jobs at Nevezyne
More biotech & pharma companies
Nextpharma
Contract pharmaceutical development, manufacturing and packaging for drug developers and supplement brandsNew on EvolcNG Biotech
Rapid in vitro diagnostic tests for healthcare professionals, patients and global partnersNew on EvolcNicox
Ophthalmic drug developer focused on glaucoma and eye allergy treatments, with products sold in the U.S. and ChinaNew on EvolcNikaia Pharmaceuticals
Develops small-molecule NIK inhibitors for cancer and autoimmune disease treatmentYoung companyNew on EvolcNoraker
Develops and manufactures resorbable biomaterial implants for surgeons treating bone defects and supporting bone regenerationNew on EvolcNordic Pharma
Specialty pharmaceutical company marketing licensed prescription products to doctors and patients in FranceNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Next.jsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Payments
- PaddleMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.